Taiwan company to enroll Vietnamese nationals in COVID-19 vaccine trial

Taipei, Nov. 2 (CNA) Taiwan’s Medigen Vaccine Biologics Corp. (MVC) has signed an agreement with Vietnam to include Vietnamese nationals in a clinical trial of the company’s COVID-19 vaccine, MVC announced Monday. The “MVC-COV1901 vaccine injection,” jointly developed by MVC and the U.S. National Institutes of Health, entered the first stage of clinical trials in Taiwan in September, according to the company. Under an agreement between MVC and Vietnam’s National Institute of Hygiene and Epidemiology (NIHE), the phase 2 trial will begin early next year and include 3,000 participants in Taiwan and Vietnam, MVC said. By enrolling both Taiwanese and…